nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Leukopenia—Dactinomycin—muscle cancer	0.00427	0.00427	CcSEcCtD
Flecainide—Gynaecomastia—Methotrexate—muscle cancer	0.00423	0.00423	CcSEcCtD
Flecainide—Atrioventricular block—Doxorubicin—muscle cancer	0.00422	0.00422	CcSEcCtD
Flecainide—Pulmonary oedema—Methotrexate—muscle cancer	0.00421	0.00421	CcSEcCtD
Flecainide—Agranulocytosis—Etoposide—muscle cancer	0.00412	0.00412	CcSEcCtD
Flecainide—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00409	0.00409	CcSEcCtD
Flecainide—Myalgia—Dactinomycin—muscle cancer	0.00406	0.00406	CcSEcCtD
Flecainide—Abnormal dreams—Doxorubicin—muscle cancer	0.00404	0.00404	CcSEcCtD
Flecainide—Discomfort—Dactinomycin—muscle cancer	0.00401	0.00401	CcSEcCtD
Flecainide—Hypoaesthesia—Etoposide—muscle cancer	0.00394	0.00394	CcSEcCtD
Flecainide—Polyuria—Methotrexate—muscle cancer	0.00391	0.00391	CcSEcCtD
Flecainide—Oedema—Dactinomycin—muscle cancer	0.00389	0.00389	CcSEcCtD
Flecainide—Neuropathy—Doxorubicin—muscle cancer	0.00384	0.00384	CcSEcCtD
Flecainide—Vertigo—Vincristine—muscle cancer	0.00383	0.00383	CcSEcCtD
Flecainide—Hepatic failure—Methotrexate—muscle cancer	0.00382	0.00382	CcSEcCtD
Flecainide—Leukopenia—Vincristine—muscle cancer	0.00381	0.00381	CcSEcCtD
Flecainide—Thrombocytopenia—Dactinomycin—muscle cancer	0.00381	0.00381	CcSEcCtD
Flecainide—Coma—Doxorubicin—muscle cancer	0.00374	0.00374	CcSEcCtD
Flecainide—Anorexia—Dactinomycin—muscle cancer	0.00371	0.00371	CcSEcCtD
Flecainide—Eye disorder—Etoposide—muscle cancer	0.0037	0.0037	CcSEcCtD
Flecainide—Convulsion—Vincristine—muscle cancer	0.00369	0.00369	CcSEcCtD
Flecainide—Flushing—Etoposide—muscle cancer	0.00368	0.00368	CcSEcCtD
Flecainide—Hypertension—Vincristine—muscle cancer	0.00368	0.00368	CcSEcCtD
Flecainide—Pulmonary oedema—Doxorubicin—muscle cancer	0.00364	0.00364	CcSEcCtD
Flecainide—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00364	0.00364	CcSEcCtD
Flecainide—Myalgia—Vincristine—muscle cancer	0.00362	0.00362	CcSEcCtD
Flecainide—Visual disturbance—Methotrexate—muscle cancer	0.00362	0.00362	CcSEcCtD
Flecainide—Immune system disorder—Etoposide—muscle cancer	0.00358	0.00358	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00354	0.00354	CcSEcCtD
Flecainide—Alopecia—Etoposide—muscle cancer	0.0035	0.0035	CcSEcCtD
Flecainide—Oedema—Vincristine—muscle cancer	0.00347	0.00347	CcSEcCtD
Flecainide—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Flecainide—Nervous system disorder—Vincristine—muscle cancer	0.00341	0.00341	CcSEcCtD
Flecainide—Thrombocytopenia—Vincristine—muscle cancer	0.0034	0.0034	CcSEcCtD
Flecainide—Hepatic function abnormal—Doxorubicin—muscle cancer	0.0034	0.0034	CcSEcCtD
Flecainide—Decreased appetite—Dactinomycin—muscle cancer	0.00338	0.00338	CcSEcCtD
Flecainide—Dysgeusia—Etoposide—muscle cancer	0.00338	0.00338	CcSEcCtD
Flecainide—Hyperhidrosis—Vincristine—muscle cancer	0.00336	0.00336	CcSEcCtD
Flecainide—Fatigue—Dactinomycin—muscle cancer	0.00335	0.00335	CcSEcCtD
Flecainide—Pain—Dactinomycin—muscle cancer	0.00333	0.00333	CcSEcCtD
Flecainide—Anorexia—Vincristine—muscle cancer	0.00331	0.00331	CcSEcCtD
Flecainide—Hepatic failure—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Flecainide—Eye pain—Doxorubicin—muscle cancer	0.00329	0.00329	CcSEcCtD
Flecainide—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00328	0.00328	CcSEcCtD
Flecainide—Hypotension—Vincristine—muscle cancer	0.00325	0.00325	CcSEcCtD
Flecainide—Ataxia—Methotrexate—muscle cancer	0.00323	0.00323	CcSEcCtD
Flecainide—Feeling abnormal—Dactinomycin—muscle cancer	0.0032	0.0032	CcSEcCtD
Flecainide—Ill-defined disorder—Etoposide—muscle cancer	0.0032	0.0032	CcSEcCtD
Flecainide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00318	0.00318	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00317	0.00317	CcSEcCtD
Flecainide—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00315	0.00315	CcSEcCtD
Flecainide—Insomnia—Vincristine—muscle cancer	0.00314	0.00314	CcSEcCtD
Flecainide—Paraesthesia—Vincristine—muscle cancer	0.00312	0.00312	CcSEcCtD
Flecainide—Malaise—Etoposide—muscle cancer	0.00311	0.00311	CcSEcCtD
Flecainide—Vertigo—Etoposide—muscle cancer	0.0031	0.0031	CcSEcCtD
Flecainide—Leukopenia—Etoposide—muscle cancer	0.00309	0.00309	CcSEcCtD
Flecainide—Abdominal pain—Dactinomycin—muscle cancer	0.00307	0.00307	CcSEcCtD
Flecainide—Body temperature increased—Dactinomycin—muscle cancer	0.00307	0.00307	CcSEcCtD
Flecainide—Loss of consciousness—Etoposide—muscle cancer	0.00303	0.00303	CcSEcCtD
Flecainide—Decreased appetite—Vincristine—muscle cancer	0.00302	0.00302	CcSEcCtD
Flecainide—Cough—Etoposide—muscle cancer	0.00301	0.00301	CcSEcCtD
Flecainide—Gastrointestinal disorder—Vincristine—muscle cancer	0.003	0.003	CcSEcCtD
Flecainide—Fatigue—Vincristine—muscle cancer	0.003	0.003	CcSEcCtD
Flecainide—Convulsion—Etoposide—muscle cancer	0.00299	0.00299	CcSEcCtD
Flecainide—Hypertension—Etoposide—muscle cancer	0.00298	0.00298	CcSEcCtD
Flecainide—Pain—Vincristine—muscle cancer	0.00297	0.00297	CcSEcCtD
Flecainide—Constipation—Vincristine—muscle cancer	0.00297	0.00297	CcSEcCtD
Flecainide—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Flecainide—Diplopia—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Flecainide—Chest pain—Etoposide—muscle cancer	0.00294	0.00294	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00292	0.00292	CcSEcCtD
Flecainide—Discomfort—Etoposide—muscle cancer	0.0029	0.0029	CcSEcCtD
Flecainide—Gastrointestinal pain—Vincristine—muscle cancer	0.00284	0.00284	CcSEcCtD
Flecainide—Confusional state—Etoposide—muscle cancer	0.00284	0.00284	CcSEcCtD
Flecainide—Cardiac arrest—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Flecainide—Ataxia—Doxorubicin—muscle cancer	0.00279	0.00279	CcSEcCtD
Flecainide—Asthenia—Dactinomycin—muscle cancer	0.00279	0.00279	CcSEcCtD
Flecainide—Dysuria—Methotrexate—muscle cancer	0.00277	0.00277	CcSEcCtD
Flecainide—Thrombocytopenia—Etoposide—muscle cancer	0.00276	0.00276	CcSEcCtD
Flecainide—Tachycardia—Etoposide—muscle cancer	0.00275	0.00275	CcSEcCtD
Flecainide—Abdominal pain—Vincristine—muscle cancer	0.00275	0.00275	CcSEcCtD
Flecainide—Body temperature increased—Vincristine—muscle cancer	0.00275	0.00275	CcSEcCtD
Flecainide—Skin disorder—Etoposide—muscle cancer	0.00273	0.00273	CcSEcCtD
Flecainide—Erectile dysfunction—Methotrexate—muscle cancer	0.00273	0.00273	CcSEcCtD
Flecainide—Hyperhidrosis—Etoposide—muscle cancer	0.00272	0.00272	CcSEcCtD
Flecainide—Photosensitivity reaction—Methotrexate—muscle cancer	0.00271	0.00271	CcSEcCtD
Flecainide—Anorexia—Etoposide—muscle cancer	0.00268	0.00268	CcSEcCtD
Flecainide—Diarrhoea—Dactinomycin—muscle cancer	0.00266	0.00266	CcSEcCtD
Flecainide—Pneumonia—Methotrexate—muscle cancer	0.00266	0.00266	CcSEcCtD
Flecainide—Hypotension—Etoposide—muscle cancer	0.00263	0.00263	CcSEcCtD
Flecainide—Renal failure—Methotrexate—muscle cancer	0.0026	0.0026	CcSEcCtD
Flecainide—Paraesthesia—Etoposide—muscle cancer	0.00253	0.00253	CcSEcCtD
Flecainide—Haematuria—Methotrexate—muscle cancer	0.00252	0.00252	CcSEcCtD
Flecainide—Dyspnoea—Etoposide—muscle cancer	0.00251	0.00251	CcSEcCtD
Flecainide—Somnolence—Etoposide—muscle cancer	0.0025	0.0025	CcSEcCtD
Flecainide—Angina pectoris—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
Flecainide—Asthenia—Vincristine—muscle cancer	0.00249	0.00249	CcSEcCtD
Flecainide—Vomiting—Dactinomycin—muscle cancer	0.00247	0.00247	CcSEcCtD
Flecainide—Agranulocytosis—Methotrexate—muscle cancer	0.00247	0.00247	CcSEcCtD
Flecainide—Rash—Dactinomycin—muscle cancer	0.00245	0.00245	CcSEcCtD
Flecainide—Decreased appetite—Etoposide—muscle cancer	0.00245	0.00245	CcSEcCtD
Flecainide—Gastrointestinal disorder—Etoposide—muscle cancer	0.00243	0.00243	CcSEcCtD
Flecainide—Fatigue—Etoposide—muscle cancer	0.00243	0.00243	CcSEcCtD
Flecainide—Pain—Etoposide—muscle cancer	0.00241	0.00241	CcSEcCtD
Flecainide—Constipation—Etoposide—muscle cancer	0.00241	0.00241	CcSEcCtD
Flecainide—Dysuria—Doxorubicin—muscle cancer	0.0024	0.0024	CcSEcCtD
Flecainide—Diarrhoea—Vincristine—muscle cancer	0.00238	0.00238	CcSEcCtD
Flecainide—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00234	0.00234	CcSEcCtD
Flecainide—Feeling abnormal—Etoposide—muscle cancer	0.00232	0.00232	CcSEcCtD
Flecainide—Hyperglycaemia—Doxorubicin—muscle cancer	0.00232	0.00232	CcSEcCtD
Flecainide—Nausea—Dactinomycin—muscle cancer	0.00231	0.00231	CcSEcCtD
Flecainide—Pneumonia—Doxorubicin—muscle cancer	0.0023	0.0023	CcSEcCtD
Flecainide—Gastrointestinal pain—Etoposide—muscle cancer	0.0023	0.0023	CcSEcCtD
Flecainide—Dizziness—Vincristine—muscle cancer	0.0023	0.0023	CcSEcCtD
Flecainide—Visual impairment—Methotrexate—muscle cancer	0.00229	0.00229	CcSEcCtD
Flecainide—Renal failure—Doxorubicin—muscle cancer	0.00225	0.00225	CcSEcCtD
Flecainide—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Flecainide—Urticaria—Etoposide—muscle cancer	0.00224	0.00224	CcSEcCtD
Flecainide—Jaundice—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Flecainide—Body temperature increased—Etoposide—muscle cancer	0.00223	0.00223	CcSEcCtD
Flecainide—Abdominal pain—Etoposide—muscle cancer	0.00223	0.00223	CcSEcCtD
Flecainide—Eye disorder—Methotrexate—muscle cancer	0.00222	0.00222	CcSEcCtD
Flecainide—Tinnitus—Methotrexate—muscle cancer	0.00221	0.00221	CcSEcCtD
Flecainide—Vomiting—Vincristine—muscle cancer	0.00221	0.00221	CcSEcCtD
Flecainide—Rash—Vincristine—muscle cancer	0.00219	0.00219	CcSEcCtD
Flecainide—Dermatitis—Vincristine—muscle cancer	0.00219	0.00219	CcSEcCtD
Flecainide—Haematuria—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Flecainide—Headache—Vincristine—muscle cancer	0.00218	0.00218	CcSEcCtD
Flecainide—Immune system disorder—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Flecainide—Agranulocytosis—Doxorubicin—muscle cancer	0.00214	0.00214	CcSEcCtD
Flecainide—Alopecia—Methotrexate—muscle cancer	0.0021	0.0021	CcSEcCtD
Flecainide—Bradycardia—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Flecainide—Nausea—Vincristine—muscle cancer	0.00206	0.00206	CcSEcCtD
Flecainide—Hypoaesthesia—Doxorubicin—muscle cancer	0.00204	0.00204	CcSEcCtD
Flecainide—Dysgeusia—Methotrexate—muscle cancer	0.00202	0.00202	CcSEcCtD
Flecainide—Asthenia—Etoposide—muscle cancer	0.00202	0.00202	CcSEcCtD
Flecainide—Pruritus—Etoposide—muscle cancer	0.00199	0.00199	CcSEcCtD
Flecainide—Visual impairment—Doxorubicin—muscle cancer	0.00198	0.00198	CcSEcCtD
Flecainide—Vision blurred—Methotrexate—muscle cancer	0.00195	0.00195	CcSEcCtD
Flecainide—Diarrhoea—Etoposide—muscle cancer	0.00193	0.00193	CcSEcCtD
Flecainide—Eye disorder—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Flecainide—Ill-defined disorder—Methotrexate—muscle cancer	0.00192	0.00192	CcSEcCtD
Flecainide—Tinnitus—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Flecainide—Flushing—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Flecainide—Malaise—Methotrexate—muscle cancer	0.00186	0.00186	CcSEcCtD
Flecainide—Dizziness—Etoposide—muscle cancer	0.00186	0.00186	CcSEcCtD
Flecainide—Immune system disorder—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Flecainide—Vertigo—Methotrexate—muscle cancer	0.00186	0.00186	CcSEcCtD
Flecainide—Leukopenia—Methotrexate—muscle cancer	0.00185	0.00185	CcSEcCtD
Flecainide—Alopecia—Doxorubicin—muscle cancer	0.00182	0.00182	CcSEcCtD
Flecainide—Cough—Methotrexate—muscle cancer	0.0018	0.0018	CcSEcCtD
Flecainide—Convulsion—Methotrexate—muscle cancer	0.00179	0.00179	CcSEcCtD
Flecainide—Vomiting—Etoposide—muscle cancer	0.00179	0.00179	CcSEcCtD
Flecainide—Rash—Etoposide—muscle cancer	0.00177	0.00177	CcSEcCtD
Flecainide—Dermatitis—Etoposide—muscle cancer	0.00177	0.00177	CcSEcCtD
Flecainide—Headache—Etoposide—muscle cancer	0.00176	0.00176	CcSEcCtD
Flecainide—Flatulence—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Flecainide—Arthralgia—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Flecainide—Chest pain—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Flecainide—Myalgia—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Flecainide—Tension—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Flecainide—Dysgeusia—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Flecainide—Discomfort—Methotrexate—muscle cancer	0.00174	0.00174	CcSEcCtD
Flecainide—Nervousness—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Flecainide—Confusional state—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Flecainide—Vision blurred—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Flecainide—Nausea—Etoposide—muscle cancer	0.00167	0.00167	CcSEcCtD
Flecainide—Ill-defined disorder—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Flecainide—Nervous system disorder—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Flecainide—Thrombocytopenia—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Flecainide—Skin disorder—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Flecainide—Hyperhidrosis—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Flecainide—Malaise—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Flecainide—Vertigo—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Flecainide—Anorexia—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Flecainide—Syncope—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Flecainide—Leukopenia—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Flecainide—Palpitations—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Flecainide—Hypotension—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Flecainide—Loss of consciousness—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Flecainide—Cough—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Flecainide—Convulsion—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Flecainide—Hypertension—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00154	0.00154	CcSEcCtD
Flecainide—Insomnia—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Flecainide—Myalgia—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Flecainide—Chest pain—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Flecainide—Arthralgia—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Flecainide—Anxiety—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Flecainide—Paraesthesia—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Flecainide—Discomfort—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Flecainide—Dyspnoea—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Flecainide—Somnolence—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Flecainide—Dry mouth—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Flecainide—Dyspepsia—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Flecainide—Confusional state—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Flecainide—Decreased appetite—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Flecainide—Oedema—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Flecainide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Flecainide—Fatigue—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Flecainide—Pain—Methotrexate—muscle cancer	0.00144	0.00144	CcSEcCtD
Flecainide—Shock—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Flecainide—Nervous system disorder—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Flecainide—Thrombocytopenia—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Flecainide—Tachycardia—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Flecainide—Skin disorder—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Flecainide—Hyperhidrosis—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Flecainide—Anorexia—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Flecainide—Feeling abnormal—Methotrexate—muscle cancer	0.00139	0.00139	CcSEcCtD
Flecainide—Gastrointestinal pain—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Flecainide—Hypotension—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Flecainide—Urticaria—Methotrexate—muscle cancer	0.00134	0.00134	CcSEcCtD
Flecainide—Body temperature increased—Methotrexate—muscle cancer	0.00133	0.00133	CcSEcCtD
Flecainide—Abdominal pain—Methotrexate—muscle cancer	0.00133	0.00133	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Flecainide—Insomnia—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Flecainide—Paraesthesia—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Flecainide—Dyspnoea—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Flecainide—Somnolence—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Flecainide—Dyspepsia—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Flecainide—Decreased appetite—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Flecainide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Flecainide—Fatigue—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Flecainide—Pain—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Flecainide—Constipation—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Flecainide—Asthenia—Methotrexate—muscle cancer	0.00121	0.00121	CcSEcCtD
Flecainide—Feeling abnormal—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Flecainide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Flecainide—Pruritus—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Flecainide—Urticaria—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Flecainide—Body temperature increased—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Flecainide—Abdominal pain—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Flecainide—Diarrhoea—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Flecainide—Dizziness—Methotrexate—muscle cancer	0.00111	0.00111	CcSEcCtD
Flecainide—Vomiting—Methotrexate—muscle cancer	0.00107	0.00107	CcSEcCtD
Flecainide—Rash—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Flecainide—Dermatitis—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Flecainide—Headache—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Flecainide—Asthenia—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Flecainide—Pruritus—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Flecainide—Nausea—Methotrexate—muscle cancer	0.001	0.001	CcSEcCtD
Flecainide—Diarrhoea—Doxorubicin—muscle cancer	0.000999	0.000999	CcSEcCtD
Flecainide—Dizziness—Doxorubicin—muscle cancer	0.000965	0.000965	CcSEcCtD
Flecainide—Vomiting—Doxorubicin—muscle cancer	0.000928	0.000928	CcSEcCtD
Flecainide—Rash—Doxorubicin—muscle cancer	0.00092	0.00092	CcSEcCtD
Flecainide—Dermatitis—Doxorubicin—muscle cancer	0.00092	0.00092	CcSEcCtD
Flecainide—Headache—Doxorubicin—muscle cancer	0.000915	0.000915	CcSEcCtD
Flecainide—Nausea—Doxorubicin—muscle cancer	0.000867	0.000867	CcSEcCtD
